Imbalanced cholesterol metabolism in Alzheimer's disease

被引：106

作者：

Zhao Xue-shan ^{[1
]}

Peng Juan ^{[1
]}

Wu Qi ^{[1
]}

Ren Zhong ^{[1
]}

Pan Li-hong ^{[1
]}

Tang Zhi-han ^{[1
]}

Jiang Zhi-sheng ^{[1
]}

Wang Gui-xue ^{[2
]}

Liu Lu-shan ^{[1
,2
]}

机构：

[1] Univ South China, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China

[2] Chongqing Univ, Coll Bioengn, Chongqing 400030, Peoples R China

来源：

CLINICA CHIMICA ACTA | 2016年 / 456卷

基金：

中国国家自然科学基金;

关键词：

Alzheimer's disease; A beta; Cholesterol; apoE; PCSK9; LRP1; AMYLOID-BETA-PEPTIDE; RECEPTOR-RELATED PROTEIN-1; BLOOD-BRAIN-BARRIER; APOLIPOPROTEIN-E; RISK-FACTORS; STATIN USE; PCSK9; ASSOCIATION; PLASMA; LDL;

D O I：

10.1016/j.cca.2016.02.024

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Alzheimer's disease (AD) is a complex and multifactorial neurodegenerative disease that is mainly caused by beta-amyloid accumulation. A large number of studies have shown that elevated cholesterol levels may perform a function in AD pathology, and several cholesterol-related gene polymorphisms are associated with this disease. Although numerous studies have shown the important function of cholesterol in AD pathogenesis and development, the underlying mechanism remains unclear. To further elucidate cholesterol metabolism disorder and AD, we first, review metabolism and regulation of the cholesterol in the brain. Second, we summarize the literature stating that hypercholesterolemia is one of the risk factors of AD. Third, we discuss the main mechanisms of abnormal cholesterol metabolism that increase the risk of AD. Finally, the relationships between AD and apolipoprotein E, PCSK9, and LRP1 are discussed in this article. (C) 2016 Elsevier B.V. All rights reserved.

引用

页码：107 / 114

页数：8

共 50 条

[1] Alzheimer's disease and cholesterol metabolism
Michikawa, Makoto
[J]. SEIKAGAKU, 2006, 78 (09): : 831 - 839
[2] The Role of Cholesterol Metabolism in Alzheimer’s Disease
Jia-Hao Sun
Jin-Tai Yu
Lan Tan
[J]. Molecular Neurobiology, 2015, 51 : 947 - 965
[3] The Role of Cholesterol Metabolism in Alzheimer's Disease
Sun, Jia-Hao
Yu, Jin-Tai
Tan, Lan
[J]. MOLECULAR NEUROBIOLOGY, 2015, 51 (03) : 947 - 965
[4] Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease
Martins, Ian J.
Berger, Tamar
Sharman, Matthew J.
Verdile, Giuseppe
Fuller, Stephanie J.
Martins, Ralph N.
[J]. JOURNAL OF NEUROCHEMISTRY, 2009, 111 (06) : 1275 - 1308
[5] Role of cholesterol metabolism in the pathogenesis of Alzheimer's disease
Allinquant, Bernadette
Clamagirand, Christine
Potier, Marie-Claude
[J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (04): : 319 - 323
[6] Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism
Wellington, CL
[J]. CLINICAL GENETICS, 2004, 66 (01) : 1 - 16
[7] Alzheimer’s Disease—A Dysfunction in Cholesterol and Lipid Metabolism
Walter J. Lukiw
Miguel Pappolla
Ricardo Palacios Pelaez
Nicolas G. Bazan
[J]. Cellular and Molecular Neurobiology, 2005, 25 : 475 - 483
[8] Alzheimer's disease - A dysfunction in cholesterol and lipid metabolism
Lukiw, WL
Pappolla, M
Pelaez, RP
Bazan, NG
[J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (3-4) : 475 - 483
[9] The link between altered cholesterol metabolism and Alzheimer's disease
Gamba, Paola
Testa, Gabriella
Sottero, Barbara
Gargiulo, Simona
Poli, Giuseppe
Leonarduzzi, Gabriella
[J]. ENVIRONMENTAL STRESSORS IN BIOLOGY AND MEDICINE, 2012, 1259 : 54 - 64
[10] MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease
Yoon, Hyejin
Flores, Luis F.
Kim, Jungsu
[J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2016, 1861 (12): : 2139 - 2147

← 1 2 3 4 5 →